The visual research atlas

The science.
Made clearer.

Clear explanations first. Scientific detail only when you want it. Explore a molecule, what it interacts with, what researchers measured and what they still don’t know.

Illustrated overview + interactive explanations

Education. Research. Perspective. For learning about research only. These simple maps are not medical advice or instructions for treatment. They do not tell you what to take, how much to take, or what to combine. Showing a possible biological process does not prove that it helps people.

Human researchCell research and a narrow FDA approval

Why does the lining inside mitochondria matter?

Explore a membrane that helps cells make usable energy. Then learn why approval for one rare condition is not approval for slowing normal aging.

How strong is the evidence?

Human evidence is still developing

  1. Limited evidence
  2. Early research
  3. Human researchCurrent category
  4. Human outcomes

Studies in people exist, but the findings may be small, narrow, mixed or still need confirmation. A hormone or cell marker is not necessarily a health benefit.

For this research: Forzinity’s approval for Barth syndrome does not establish healthy-person longevity benefits.

An editorial guide—not a validated score, a percentage, a safety rating or an approval badge. Regulatory status is separate. More research does not mean fewer risks.

CONCEPTUAL MAP / NOT TO SCALE

Select a step to explore · Use arrow keys

These are simple illustrations, not exact pictures of molecules. Arrows connect ideas; they do not prove that every step happens in people, that a treatment works, or that it is safe.

1 / 4

STEP 01 / IN PLAIN LANGUAGE

A peptide studied in mitochondria

SS-31, or elamipretide, is a small peptide studied for how it interacts with mitochondria—the cell’s energy-making structures. Research preparations are not interchangeable with an approved medicine.

Based on: Research on the molecule

What this does not prove: The same molecule name does not guarantee the same product quality or approval.

Want the scientific detail?

SS-31 / Elamipretide

Elamipretide interacts with the inner mitochondrial membrane. Research-grade SS-31 and an approved finished medication are not interchangeable.

Evidence context: Molecular pharmacology

Important limit: A shared molecule name does not establish identical formulation, quality or regulatory status.

Keep the distinction: Forzinity’s approval for Barth syndrome does not establish healthy-person longevity benefits.

A dated view of the research

Selected sources checked:

This date tells you when the linked sources were checked. It does not mean every new study or every part of a medicine’s safety label was reviewed. This site does not monitor changes or update itself automatically. Research and regulations can change. Follow the official source links to check for later information.

See 2 sources & what was checked

Scientific detail is optional. Publication dates tell you when studies appeared; the source-check date tells you when these links and selected information were checked. This is a selected reading list, not a review of every study or an independent medical endorsement.

Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.